Bristol Myers Squibb (BMY) Current Assets (2009 - 2026)
Bristol Myers Squibb (BMY) reported Current Assets of $27.2 billion for Q1 2026, down 11.61% year-over-year from $30.8 billion in Q1 2025, and down 7.42% on a QoQ basis from $29.4 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Current Assets data on file, last reported at $27.2 billion in Q1 2026.
- Quarterly Current Assets fell 11.61% year-over-year to $27.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.2 billion (down 11.61% YoY) and the FY2025 annual result came in at $29.4 billion, down 1.31% from the prior year.
- Current Assets retreated to $27.2 billion in Q1 2026 per BMY's latest filing, from $29.4 billion in the prior quarter.
- Across five years, Current Assets topped out at $35.6 billion in Q3 2025 and bottomed at $26.8 billion in Q3 2022.
- The 5-year median for Current Assets is $28.7 billion (2024), against an average of $29.3 billion.
- The widest annual swing landed in 2022, when Current Assets fell 18.01%; it then gained 26.91% in 2025.
- Tracing BMY's Current Assets over 5 years: stood at $27.3 billion in 2022, then grew by 16.49% to $31.8 billion in 2023, then decreased by 6.26% to $29.8 billion in 2024, then dropped by 1.31% to $29.4 billion in 2025, then decreased by 7.42% to $27.2 billion in 2026.
- Per Business Quant, the three latest BMY Current Assets figures stand at $27.2 billion (Q1 2026), $29.4 billion (Q4 2025), and $35.6 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 54.84 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 59.17 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 33.53 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 35.02 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 31.48 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 18.64 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 42.82 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 27.21 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 23.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.21 Bn |
| Dec 31, 2025 | 29.39 Bn |
| Sep 30, 2025 | 35.63 Bn |
| Jun 30, 2025 | 33.22 Bn |
| Mar 31, 2025 | 30.78 Bn |
| Dec 31, 2024 | 29.78 Bn |
| Sep 30, 2024 | 28.08 Bn |
| Jun 30, 2024 | 26.89 Bn |
| Mar 31, 2024 | 28.67 Bn |
| Dec 31, 2023 | 31.77 Bn |
| Sep 30, 2023 | 27.63 Bn |
| Jun 30, 2023 | 28.07 Bn |
| Mar 31, 2023 | 27.09 Bn |
| Dec 31, 2022 | 27.27 Bn |
| Sep 30, 2022 | 26.80 Bn |
| Jun 30, 2022 | 30.19 Bn |
| Mar 31, 2022 | 30.12 Bn |
| Dec 31, 2021 | 33.26 Bn |
| Sep 30, 2021 | 31.44 Bn |
| Jun 30, 2021 | 29.16 Bn |
| Mar 31, 2021 | 27.11 Bn |
| Dec 31, 2020 | 30.19 Bn |
| Sep 30, 2020 | 34.28 Bn |
| Jun 30, 2020 | 34.34 Bn |
| Mar 31, 2020 | 31.85 Bn |
| Dec 31, 2019 | 29.35 Bn |
| Sep 30, 2019 | 40.19 Bn |
| Jun 30, 2019 | 37.72 Bn |
| Mar 31, 2019 | 17.09 Bn |
| Dec 31, 2018 | 17.72 Bn |
| Sep 30, 2018 | 14.87 Bn |
| Jun 30, 2018 | 13.87 Bn |
| Mar 31, 2018 | 14.65 Bn |
| Dec 31, 2017 | 14.85 Bn |
| Sep 30, 2017 | 15.05 Bn |
| Jun 30, 2017 | 14.32 Bn |
| Mar 31, 2017 | 13.62 Bn |
| Dec 31, 2016 | 13.70 Bn |
| Sep 30, 2016 | 13.20 Bn |
| Jun 30, 2016 | 12.30 Bn |
| Mar 31, 2016 | 11.22 Bn |
| Dec 31, 2015 | 10.42 Bn |
| Sep 30, 2015 | 12.93 Bn |
| Jun 30, 2015 | 13.06 Bn |
| Mar 31, 2015 | 14.93 Bn |
| Dec 31, 2014 | 14.61 Bn |
| Sep 30, 2014 | 14.18 Bn |
| Jun 30, 2014 | 14.06 Bn |
| Mar 31, 2014 | 14.01 Bn |
| Dec 31, 2013 | 18.92 Bn |
| Sep 30, 2013 | 10.63 Bn |
| Jun 30, 2013 | 10.49 Bn |
| Mar 31, 2013 | 10.08 Bn |
| Dec 31, 2012 | 9.52 Bn |
| Sep 30, 2012 | 9.28 Bn |
| Jun 30, 2012 | 11.01 Bn |
| Mar 31, 2012 | 11.77 Bn |
| Dec 31, 2011 | 15.32 Bn |
| Sep 30, 2011 | 14.87 Bn |
| Jun 30, 2011 | 14.78 Bn |
| Mar 31, 2011 | 13.30 Bn |
| Dec 31, 2010 | 13.27 Bn |
| Dec 31, 2009 | 13.96 Bn |
| Sep 30, 2009 | 13.39 Bn |
| Jun 30, 2009 | 14.57 Bn |